A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma.
Br J Haematol
; 191(5): e103-e106, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-32862455
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Tumor Suppressor Protein p53
/
Lymphoma, Mantle-Cell
/
Mutation
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2020
Document type:
Article
Affiliation country:
Czech Republic
Country of publication:
United kingdom